05 Nov 2026, 06:50 IST
Anthem Biosciences Limited
HDFC Securities · ADD · target INR 960
The report notes EBITDA growth in line with estimates on gross margin expansion and reiterates ADD with a revised target price.
From HSIE Results Daily 05 Nov 26 HSIE, written by HDFC Securities. Orivam summarised it; the view is HDFC Securities's, not Orivam's.
Open the original PDF →Research PDFs are often removed by the firms that publish them. The summary above is kept so this page still means something if that happens.